Diabetes Clinical resources
Pre-Diabetes - Is this a significant disease entity or a harmless bystander? Dr Alkesh MaganRetina - Clinical Resources
Kite and Kestrel: 52 Week Results from two phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
About Ultibro Breezhaler
About Entreso
About IIevro®
Jalra
PI JALRA is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients with type 2 diabetes mellitus, as add-on therapy, in combination with metformin, a sulphonylurea (SU), or insulinAbout Lucentis®
×
Medical Information Request
×